NewcelX Ltd. (NCEL)
Last updated: 2026-10-24 13:36:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
NewcelX Ltd. (NCEL) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $2.60, with a market capitalization of $14.79M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.83 to $7.64. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$14.79M | |
$2.53 | |
$7.64 | |
$1.83 | |
$2.56 | |
10.30K | |
8.61K | |
-- | |
$7.64 | |
$1.83 | |
-- | |
-- |
NewcelX Ltd. (NCEL) Latest Closing Stock Price
NewcelX Ltd. (NCEL) last closed at $2.56 as of 2026-10-23 23:31:00, unchanged from the previous close of $2.56.
During the latest regular trading session, NCEL traded between $1.83 and $7.64, with a volume of 10.30K shares. The closing price was near the lower end and near the lower end of its 52-week range.
NewcelX Ltd. (NCEL) 7-Day Stock Price Change
Over the past seven days, NewcelX Ltd. (NCEL) moved from $2.85 to $2.60, representing a decline of 8.81% ($0.25).
The stock traded between $2.36 and $3.14 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 11.21 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
NCEL 52-Week Price Position
Position in Range: 13.2%
NCEL is currently trading at $2.60, placing it 13.2% of the way from its 52-week low of $1.83 to its 52-week high of $7.64. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is NewcelX Ltd. (NCEL)?
NewcelX Ltd is a clinical-stage biopharmaceutical company focused on developing transformative therapies. Built on a validated human pluripotent stem cell (hPSC) platform, the Company's main program, NCEL-101, is designed to restore functional insulin production through scalable, off-the-shelf cell replacement. It is advancing a comprehensive therapeutic approach for Type 1 Diabetes, integrating cell therapy, immune protection, and translational science, including a phase IIa clinical trial for the treatment of Amyotrophic Lateral Sclerosis (ALS) in the field of regenerative medicine, as well as the development of treatments for Central Nervous System (CNS) disorders, including Narcolepsy, utilizing its Doxa platform. Its products are Holistic, IsletRx, AstroRx, and the DOXA platform.
NewcelX Ltd. Information
| Employees | 4 |
| Exchange | NASDAQ |
| Company Website |
How to Buy NewcelX Ltd. (NCEL) Stock on MEXC
Eligible investors can buy real shares of NewcelX Ltd. (NCEL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is NewcelX Ltd. (NCEL) stock price today?
2.Is NCEL stock going up or down today?
3.What is NCEL pre-market price?
4.What is NCEL after-hours price?
5.Is NCEL stock trading now?
6.Where does NCEL sit relative to its 52-week high and low?
7.What sector is NewcelX Ltd. in?
8.What is NewcelX Ltd.'s market capitalization and where is it listed?
9.How is NCEL valued in terms of P/E ratio and EPS?
10.Does NewcelX Ltd. pay a dividend?
Explore More US Stocks
Search Stocks
NCEL Stock Calculator
Estimate the value between NCEL shares and USD.
NCEL Shares to USD
1.00 NCEL shares = 2.599 USD
Calculations are estimates based on the latest available price and are for reference only.


